Sabby Management’s Cocrystal Pharma COCP Stock Holding History

Sabby Management’s Portfolio COCP Stock Details COCP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-66,172	Closed	-$132K	–	99
2023 Q1	$132K	Sell	66,172 -354,538	-84%	-$792K	0.11%	52
2022 Q4	$820K	Sell	420,710 -19,645	-4%	-$50.4K	0.72%	19
2022 Q3	$1.54M	Sell	440,355 -50,389	-10%	-$236K	1.94%	13
2022 Q2	$2.41M	Buy	490,744 +23,074	+5%	+$123K	1.64%	11
2022 Q1	$3.09M	Sell	467,670 -10,507	-2%	-$69.9K	0.46%	12
2021 Q4	$3.73M	Buy	478,177 +47,726	+11%	+$488K	0.54%	25
2021 Q3	$5.42M	Sell	430,451 -78,770	-15%	-$1.04M	0.73%	14
2021 Q2	$7.64M	Buy	+509,221	New	+$7.74M	1.08%	10
2020 Q4	–	Sell	-222,274	Closed	-$2.48M	–	120
2020 Q3	$2.48M	Buy	+222,274	New	+$4.06M	0.37%	40
2020 Q2	–	Sell	-32,684	Closed	-$278K	–	107
2020 Q1	$278K	Buy	+32,684	New	+$308K	0.12%	47

Other funds holding COCP

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Parallel Advisors San Francisco, California $6.56B AUM 32.24% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Sabby Management's COCP Position: Q2 2023 in Review

Sabby Management sold out of Cocrystal Pharma (COCP) in Q2 2023, closing a stake of 66,172 shares — an estimated $132K sold.

Sabby Management first reported a position in COCP in Q1 2020 and held it in 10 quarters. The position peaked at $7.64M in Q2 2021. 20 funds tracked by Wall St. Rank hold COCP as of Q2 2023.

Sabby Management reported no remaining Cocrystal Pharma position as of Q2 2023 after selling out during the quarter.
Sabby Management sold 66,172 Cocrystal Pharma shares in Q2 2023, an estimated $132K.
Sabby Management first reported a position in Cocrystal Pharma in Q1 2020 and held it in 10 quarters.
Sabby Management's Cocrystal Pharma position peaked at $7.64M in Q2 2021.
20 funds tracked by Wall St. Rank held Cocrystal Pharma as of Q2 2023.

Based on Sabby Management's 13F filing for Q2 2023, filed 14 Aug 2023.